CureSearch PEDS 2022 Impact Statement & Next Steps

The 2022 Pediatric Early Development Symposium (PEDS): Leveraging Big Data to Advance Pediatric Clinical Trials was another collaborative success! 

This event convened leaders from all areas of pediatric oncology – pharmaceutical and biotechnology companies, clinical research organizations, academic leaders, parents and patient advocates, venture capitalists, regulators, and like-minded partners. 

The recurring themes throughout the Symposium were: 

  • Pediatric drug development must be treated as a global enterprise 
  • More collaboration is necessary between investigators (academics) and organizations, including industry, to generate data that move regulatory requirements forward in relevant targets 
  • There must be a concerted effort to improve data collection through quality standards and simplification 

Derived from the many discussions, questions from attendees, and group conversations over the three-day symposium, we are pleased to share the 2022 PEDS Impact Statement, outlining three key impact areas CureSearch will address over the next year.

Pin It on Pinterest

Scroll to Top